Clinical Diagnostics Products & Reviews

The MBT FAST™ Shuttle significantly reduces the time required for matrix crystallization during MALDI-TOF analysis by at least 50%. This compact benchtop device provides an ideal environment for optimized, standardized, and reproducible matrix crystallization and other droplet assays, making sample preparation more efficient and less time-consuming.

≥99.5% (titration), crystalline powder

lyophilized powder, 250 units/mg solid (using pyrogallol)

Lyophilized powder, ≥4000 units/mg protein (biuret), Chromatographically purified

Reagent grade, ≥99.0% (titration), crystalline

lyophilized powder, ≥2000 units/mg protein

The MBT Pilot® simplifies sample positioning with its microprojection technology, guiding you to the next available MALDI target plate position. This helps prevent sample mix-ups, boosts productivity, and offers an ergonomic setup with optimized hand rests and on-screen help text. Seamlessly integrated with MALDI Biotyper® software, this workstation ensures a fully traceable and paperless process.

Phytohemagglutinin PHA-P, lyophilized powder

≥99.9% (titration), crystalline

buffered aqueous solution, ≥500 units/mL

Developing a precise, accurate, and reliable assay is never easy. From raw material sourcing, to technical considerations, to optimization and ultimate scale-up, a development team counters challenges that strain resources and delay timetables. Savvy developers recognize that assay development and optimization move smoother when optimal raw materials and expert support are identified early in the process.

Type I-S, 65-85% protein (≥75% of protein is clottable)

saline solution, 3-7 TIU/mg protein

≥99.5% (titration)

BioPerformance Certified, meets EP, USP testing specifications, suitable for cell culture, ≥99.9% (titration)

Powder, pH 7.4, with 0.05% Tween® 20

lyophilized powder, 20 kDa

lyophilized powder, ≥900 units/mg protein

1,6-α-D-Glucan 6-glucanohydrolase

organic base and chaeotropic agent, ≥99% (titration)

BioPerformance Certified, ≥99.5% (titration), suitable for cell culture

Lyophilized powder, ≥6 units/mg solid

Type III-A, ≥85% RNase A basis (SDS-PAGE), 85-140 Kunitz units/mg protein

Bruker's MBT Sepsityper® solution is designed to integrate seamlessly with the MALDI Biotyper®. This powerful combination enables the identification of pathogens directly from positive blood cultures in just 15-20 minutes, offering a cost-effective and efficient workflow that can significantly enhance patient care.

USP Testing Specific